Literature DB >> 7860725

cGMP inhibition of heart phosphodiesterase: is it clinically relevant?

J A Beavo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7860725      PMCID： PMC295485          DOI： 10.1172/JCI117683

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.

Authors:  P F Méry; S M Lohmann; U Walter; R Fischmeister
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 2.  Cyclic-GMP-regulated enzymes and their possible physiological functions.

Authors:  U Walter
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

Review 3.  Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells.

Authors:  T F McDonald; S Pelzer; W Trautwein; D J Pelzer
Journal:  Physiol Rev       Date:  1994-04       Impact factor: 37.312

Review 4.  The development of positive inotropic agents for chronic heart failure: how have we gone astray?

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

5.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

6.  Elevation of guanosine 3',5'-cyclic phosphate in rat heart after perfusion with acetylcholine.

Authors:  W J George; J B Polson; A G O'Toole; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

7.  An obligatory role for nitric oxide in autonomic control of mammalian heart rate.

Authors:  X Han; Y Shimoni; W R Giles
Journal:  J Physiol       Date:  1994-04-15       Impact factor: 5.182

8.  Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.

Authors:  K A Narahara
Journal:  Am Heart J       Date:  1991-05       Impact factor: 4.749

9.  Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Authors:  A M Feldman; M R Bristow; W W Parmley; P E Carson; C J Pepine; E M Gilbert; J E Strobeck; G H Hendrix; E R Powers; R P Bain
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

10.  Nitric oxide regulates the calcium current in isolated human atrial myocytes.

Authors:  M Kirstein; M Rivet-Bastide; S Hatem; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808
  10 in total
  2 in total

1.  G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.

Authors:  M J P M T Meens; N J A Mattheij; P B van Loenen; L J A Spijkers; P Lemkens; J Nelissen; M G Compeer; A E Alewijnse; J G R De Mey
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion.

Authors:  Hee Kee Kim; Seon-Hee Hwang; Elizabeth Oh; Salahadin Abdi
Journal:  Front Pharmacol       Date:  2017-12-04       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.